{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T14:18:19Z","timestamp":1784297899720,"version":"3.55.0"},"reference-count":78,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Am Med Inform Assoc"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1136\/amiajnl-2013-002116","type":"journal-article","created":{"date-parts":[[2013,11,13]],"date-time":"2013-11-13T03:48:57Z","timestamp":1384314537000},"page":"547-557","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":128,"title":["ICD-10 codes used to identify adverse drug events in administrative data: a systematic review"],"prefix":"10.1093","volume":"21","author":[{"given":"Corinne M","family":"Hohl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei","family":"Karpov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Reddekopp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Stausberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,5,1]]},"reference":[{"key":"2015062501571407000_21.3.547.1","doi-asserted-by":"crossref","unstructured":"Gu Q Dillon CF Burt VL . Prescription drug use continues to increase: US prescription drug data for 2007\u20132008. NCHS Data Brief 2010. http:\/\/www.cdc.gov\/nchs\/data\/databriefs\/db42.pdf (accessed 9 Feb 2013).","DOI":"10.1037\/e665492010-001"},{"key":"2015062501571407000_21.3.547.2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-140-10-200405180-00017"},{"key":"2015062501571407000_21.3.547.3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.279.15.1216"},{"key":"2015062501571407000_21.3.547.4","unstructured":"Slone Epidemiology Center. Patterns of Medication Use in the United States 2004: a Report from the Slone Survey. 2004. http:\/\/www.bu.edu\/slone\/SloneSurvey\/AnnualRpt\/SloneSurveyWebReport2006.pdf (accessed April 2010)."},{"key":"2015062501571407000_21.3.547.5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.9.1107"},{"key":"2015062501571407000_21.3.547.6","unstructured":"Tamblyn R . Evidence-based utilization of prescription drugs: challenges and directions for the future in Canada. Institute for Research on Public Policy, 2001."},{"key":"2015062501571407000_21.3.547.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2011.01.003"},{"key":"2015062501571407000_21.3.547.8","unstructured":"WHO. International drug monitoring: the role of national centres. Report of a WHO Meeting, Vol 498. Geneva: World Health Organization; 1972:1\u201344."},{"key":"2015062501571407000_21.3.547.9","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.329.7456.15"},{"key":"2015062501571407000_21.3.547.10","doi-asserted-by":"publisher","DOI":"10.1001\/jama.279.15.1200"},{"key":"2015062501571407000_21.3.547.11","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1L037"},{"key":"2015062501571407000_21.3.547.12","unstructured":"Wiffen P Gill M Edwards J . Adverse drug reactions in hospital patients. A systematic review of the prospective and retrospective studies. Bandolier extra 2002. http:\/\/www.medicine.ox.ac.uk\/bandolier\/extraforbando\/adrpm.pdf"},{"key":"2015062501571407000_21.3.547.13","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1997.03540280039031"},{"key":"2015062501571407000_21.3.547.14","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.168.14.1561"},{"key":"2015062501571407000_21.3.547.15","unstructured":"The WHO Research Priority Setting Working Group. Global priorities for research in patient safety (first edition). Geneva: World Health Organization, 2008."},{"key":"2015062501571407000_21.3.547.16","doi-asserted-by":"publisher","DOI":"10.1038\/ncprheum0652"},{"key":"2015062501571407000_21.3.547.17","unstructured":"Agency for Healthcare Research and Quality. Developing a Protocol for Observational Comparative Effectiveness Research (OCER): A User's Guide (XXX under Contract No. XXX HHSA). 2012. http:\/\/www.effectivehealthcare.ahrq.gov\/ehc\/products\/440\/1067\/AHRQ_CER_Protocol_User_s_Guide_DRAFT-COPY_AllChapters.pdf"},{"key":"2015062501571407000_21.3.547.18","unstructured":"World Health Organization. International statistical classification of diseases and related health problems 10th revision. 2004; Second, Volume 3. http:\/\/apps.who.int\/classifications\/icd10\/browse\/2010\/en (accessed 14 Jul 2011)."},{"key":"2015062501571407000_21.3.547.19","unstructured":"Centre for Reviews and Dissemination. Systematic reviews: CDR's guidance for undertaking reviews in health care. 3rd edn. York: York Publishing Services Ltd, 2009."},{"key":"2015062501571407000_21.3.547.20","unstructured":"Dreyer NA Schneeweiss S McNeil BJ . GRACE Principles: recognizing high-quality observational studies of comparative effectiveness. Am J Manag Care 2010;16:467\u201371."},{"key":"2015062501571407000_21.3.547.21","unstructured":"Stausberg J Hasford J . Identification of adverse drug events: the use of ICD-10 coded diagnoses in routine hospital data. Dtsch Arztebl Int 2010;107:23\u20139."},{"key":"2015062501571407000_21.3.547.22","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6963-11-134"},{"key":"2015062501571407000_21.3.547.23","doi-asserted-by":"crossref","unstructured":"Barrow P Waller P Wise L . Comparison of hospital episodes with \u2018drug-induced\u2019 disorders and spontaneously reported adverse drug reactions. Br J Clin Pharmacol 2005;61:233\u20137.","DOI":"10.1111\/j.1365-2125.2005.02554.x"},{"key":"2015062501571407000_21.3.547.24","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-009-9300-5"},{"key":"2015062501571407000_21.3.547.25","unstructured":"Bergman U Mejyr S Holm L . Pharmacovigilance and patient safety\u2014experiences from a Regional Pharmacovigilance Centre (RPVC) in Stockholm, Sweden. Basic Clin Pharmacol Toxicol 2010;107:111."},{"key":"2015062501571407000_21.3.547.26","doi-asserted-by":"publisher","DOI":"10.1046\/j.0306-5251.2001.01454.x"},{"key":"2015062501571407000_21.3.547.27","doi-asserted-by":"publisher","DOI":"10.1177\/1076029608319441"},{"key":"2015062501571407000_21.3.547.28","unstructured":"Gaus W Westendorf J Diebow R . Identification of adverse drug reactions by evaluation of a prescription database, demonstrated for \u201cRisk of Bleeding\u201d. Methods Inf Med 2005;5:697\u2013703."},{"key":"2015062501571407000_21.3.547.29","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2006.02633.x"},{"key":"2015062501571407000_21.3.547.30","doi-asserted-by":"publisher","DOI":"10.3201\/eid1505.081154"},{"key":"2015062501571407000_21.3.547.31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2008.03229.x"},{"key":"2015062501571407000_21.3.547.32","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2005.00785.x"},{"key":"2015062501571407000_21.3.547.33","unstructured":"Osmont M Bayat S Polard E . ICD-10 based queries to detect serious adverse drug reactions: 1-year evaluation in Rennes University Hospital. Fundam Clin Pharmacol 2011;25:21."},{"key":"2015062501571407000_21.3.547.34","doi-asserted-by":"crossref","unstructured":"Patel H Bell D Molokhia M . Trends in hospital admissions for adverse drug reactions in England: analysis of national hospital episode statistics 1998\u20132005. BMC Clin Pharmacol 2007;7:1\u201311.","DOI":"10.1186\/1472-6904-7-9"},{"key":"2015062501571407000_21.3.547.35","doi-asserted-by":"crossref","unstructured":"Waller P Shaw M Ho D . Hospital admissions for \u2018drug-induced\u2019 disorders in England: a study using the Hospital Episodes Statistics (HES) database. Br J Clin Pharmacol 2004;59:213\u201319.","DOI":"10.1111\/j.1365-2125.2004.02236.x"},{"key":"2015062501571407000_21.3.547.36","doi-asserted-by":"publisher","DOI":"10.1258\/jrsm.2010.100113"},{"key":"2015062501571407000_21.3.547.37","unstructured":"Centers for Disease Control and Prevention. Unintentional and undetermined poisoning deaths-11 states, 1990\u20132001. MMWR 2004;53:233."},{"key":"2015062501571407000_21.3.547.38","doi-asserted-by":"crossref","unstructured":"Hohl CM Kuramoto L Yu E . Evaluating Adverse Drug Event Reporting in Administrative Data from Emergency Departments: A Validation Study. BMC Health Services Research. In press.","DOI":"10.1186\/1472-6963-13-473"},{"key":"2015062501571407000_21.3.547.39","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1P592"},{"key":"2015062501571407000_21.3.547.40","unstructured":"Wu C . Adverse drug reactions in the Emergency Department Population in Ontario: analysis of National Ambulatory Care Reporting System and Discharge Abstract Database 2003\u20132007. Toronto: Graduate Department of Health Policy, Management and Evaluation, University of Toronto, 2009."},{"key":"2015062501571407000_21.3.547.41","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.04.1790"},{"key":"2015062501571407000_21.3.547.42","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200730060-00007"},{"key":"2015062501571407000_21.3.547.43","doi-asserted-by":"publisher","DOI":"10.1016\/j.phr.2004.09.001"},{"key":"2015062501571407000_21.3.547.44","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.167.13.1414"},{"key":"2015062501571407000_21.3.547.45","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0b013e31819b5bdc"},{"key":"2015062501571407000_21.3.547.46","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6963-7-159"},{"key":"2015062501571407000_21.3.547.47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2006.10.004"},{"key":"2015062501571407000_21.3.547.48","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21794"},{"key":"2015062501571407000_21.3.547.49","doi-asserted-by":"crossref","unstructured":"Burgess CL Holman CDAJ Satti AG . Adverse drug reactions in older Australians, 1981\u20132002. Med J Aust 2005;182:267\u201370.","DOI":"10.5694\/j.1326-5377.2005.tb06698.x"},{"key":"2015062501571407000_21.3.547.50","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0b013e31822efb09"},{"key":"2015062501571407000_21.3.547.51","doi-asserted-by":"publisher","DOI":"10.1002\/j.2055-2335.2009.tb00698.x"},{"key":"2015062501571407000_21.3.547.52","doi-asserted-by":"crossref","unstructured":"Jackson TJ Michel JL Roberts RF . A classification of hospital-acquired diagnoses for use with routine hospital data. Med J Aust 2009;191:544\u20138.","DOI":"10.5694\/j.1326-5377.2009.tb03307.x"},{"key":"2015062501571407000_21.3.547.53","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1762.1999.00286.x"},{"key":"2015062501571407000_21.3.547.54","doi-asserted-by":"publisher","DOI":"10.1093\/intqhc\/mzg085"},{"key":"2015062501571407000_21.3.547.55","unstructured":"Sood S Howell J Sundarajan V . Epidemiology of paracetamol overdose in Victoria over 7 years. J Gastroenterol Hepatol 2010;25 (Suppl. 3):A34."},{"key":"2015062501571407000_21.3.547.56","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.a2752"},{"key":"2015062501571407000_21.3.547.57","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2006.02839.x"},{"key":"2015062501571407000_21.3.547.58","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp080122"},{"key":"2015062501571407000_21.3.547.59","unstructured":"Rhee CW Kang DY Park SY . Concomitant use of diuretics and risk of digoxin intoxication among elderly heart failure patients. Pharmacoepidemiol Drug Saf 2010;19:S267."},{"key":"2015062501571407000_21.3.547.60","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2010.04292.x"},{"key":"2015062501571407000_21.3.547.61","unstructured":"Australian Commission on Safety and Quality in Healthcare. Classification of Hospital Acquired Diagonses. 2012; 4. http:\/\/www.safetyandquality.gov.au\/our-work\/information-strategy\/health-information-standards\/ (accessed 6 Jan 2013)."},{"key":"2015062501571407000_21.3.547.62","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-7843.2009.00399.x"},{"key":"2015062501571407000_21.3.547.63","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsa1103053"},{"key":"2015062501571407000_21.3.547.64","doi-asserted-by":"publisher","DOI":"10.1067\/mem.2001.119456"},{"key":"2015062501571407000_21.3.547.65","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.071594"},{"key":"2015062501571407000_21.3.547.66","unstructured":"Parternship for Patients. http:\/\/partnershipforpatients.cms.gov\/about-the-partnership\/aboutthepartnershipforpatients.html (accessed 29 Apr 2013)."},{"key":"2015062501571407000_21.3.547.67","unstructured":"Accreditation Canada. Required Orgnanizational Practice. 2011. http:\/\/www.accreditation.ca\/uploadedFiles\/ROP%20Handbook%20EN.pdf (accessed 20 Jun 2011)."},{"key":"2015062501571407000_21.3.547.68","unstructured":"Improvement IfH. 5 Million Lives Campaign. Getting Started, Kit: Prevent Adverse Drug Events (Medication Reconciliation) How-to Guide. Protective 5 Million Lives from harm . Cambridge, MA: Institute for Healthcare Improvement, 2008."},{"key":"2015062501571407000_21.3.547.69","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2012.2246"},{"key":"2015062501571407000_21.3.547.70","unstructured":"Velentgas P Dreyer N Nourjah P ., eds. Developing a protocol for observational comparative effectiveness research: a user's guide. AHRQ Publication No. 12(13)-EHC099. 2013. http:\/\/www.effectivehealthcare.ahrq.gov\/Methods-OCER.cfm"},{"key":"2015062501571407000_21.3.547.71","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2011.235"},{"key":"2015062501571407000_21.3.547.72","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02799-9"},{"key":"2015062501571407000_21.3.547.73","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1991.03470200059035"},{"key":"2015062501571407000_21.3.547.74","doi-asserted-by":"publisher","DOI":"10.1136\/jamia.1998.0050305"},{"key":"2015062501571407000_21.3.547.75","doi-asserted-by":"publisher","DOI":"10.1001\/jama.280.15.1317"},{"key":"2015062501571407000_21.3.547.76","unstructured":"VHA. Monitoring adverse drug events: finding the needle in haystack. Irving, Texas: VHA Research Series, 2002."},{"key":"2015062501571407000_21.3.547.77","unstructured":"Stausberg J . ICD-10-GM-Kodes f\u00fcr unerw\u00fcnschte Arzneimittelereignisse (UAE). 2012. http:\/\/www.ekmed.de\/routinedaten\/main4.php (accessed 11 Dec 2012)."},{"key":"2015062501571407000_21.3.547.78","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-002-0467-0"}],"updated-by":[{"DOI":"10.1136\/amiajnl-2013-002116corr1","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000}}],"container-title":["Journal of the American Medical Informatics Association"],"original-title":[],"language":"en","deposited":{"date-parts":[[2020,8,7]],"date-time":"2020-08-07T21:06:59Z","timestamp":1596834419000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jamia\/article-lookup\/doi\/10.1136\/amiajnl-2013-002116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":78,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2014,5,1]]},"published-print":{"date-parts":[[2014,5]]}},"alternative-id":["10.1136\/amiajnl-2013-002116"],"URL":"https:\/\/doi.org\/10.1136\/amiajnl-2013-002116","relation":{"correction":[{"id-type":"doi","id":"10.1136\/amiajnl-2013-002116corr1","asserted-by":"object"}]},"ISSN":["1067-5027","1527-974X"],"issn-type":[{"value":"1067-5027","type":"print"},{"value":"1527-974X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5]]}}}